From the WSJ Blog:
Ken Frazier from Merck spoke in New York City recently, and he addressed the Vytorin frenzy in the media in recent “We really feel that the Enhance data that has been put out into the public sphere has been mischaracterized,” he said.
Read more about Merck's view here.
